EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Microenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells

Miao Yuan, Yang Wu, Jing Zheng, Chaoran Wang, Jiarong Wang, Yifan Zheng, Yunqi Wang, Baiqi Wang iD

International Journal of Nanomedicine · 2026-05 · Volume 21 · 1-21

DOI: 10.2147/ijn.s604452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-05. Verfasst von Miao Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin, 300070, People's Republic of China. Hauptthemen laut MEDLINE: Doxorubicin, Ferroptosis, Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Doxorubicin (DOX) is a cornerstone chemotherapeutic for breast cancer; however, its clinical efficacy is limited by inefficient intracellular delivery and dose-limiting off-target toxicity. Microenvironment-responsive nanoplatforms offer a promising strategy to enhance tumor selectivity and therapeutic performance.

Methods

A core-shell nanosystem (UTMD) was constructed by coating an NH2-MIL-88B(Fe) metal-organic framework (Fe-MOF) shell onto a UCNP@TiO2 scaffold. The Fe-MOF shell was designed as a dual pH- and glutathione (GSH)-responsive gatekeeper for controlled DOX release. The nanosystem was characterized for structural features, drug loading, and stimulus-responsive release behavior. Cellular uptake, intracellular trafficking, cytotoxicity, and redox-related biochemical changes were evaluated in MCF-7 breast cancer cells and HEK-293 normal cells.

Results

UTMD achieved high encapsulation efficiency (86.5%) and maintained stability under physiological conditions, while enabling accelerated DOX release in acidic and reducing environments. The nanosystem enhanced cellular internalization and promoted nuclear accumulation of DOX in MCF-7 cells. In addition, UTMD induced significant intracellular redox imbalance, characterized by GSH depletion, increased reactive oxygen species levels, and elevated lipid peroxidation, accompanied by mitochondrial membrane potential depolarization. These changes are consistent with ferroptosis-associated oxidative damage. Compared with free DOX, UTMD exhibited improved cytocompatibility in HEK-293 cells.

Discussion

The Fe-MOF shell functions as a microenvironment-responsive gatekeeper that coordinates controlled drug release with iron-mediated oxidative stress. This integrated design links chemotherapy with ferroptosis-associated mechanisms, improving therapeutic selectivity and mechanistic interpretability.

Conclusion

UTMD represents a microenvironment-activated nanoplatform that enables controlled DOX delivery and ferroptosis-associated oxidative damage. This strategy enhances antitumor efficacy while reducing off-target toxicity, offering potential for improved breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinFerroptosisBreast NeoplasmsNanoparticlesHumansMCF-7 CellsDelayed-Action PreparationsFemaleOxidative StressTumor MicroenvironmentHEK293 CellsCell SurvivalGlutathioneDrug LiberationHydrogen-Ion Concentration

Stichwörter der Autor:innen

Fe-based metal–organic frameworkbreast cancerdoxorubicin deliveryferroptosislipid peroxidationpH/GSH-responsive nanoplatform

Substanzen

DoxorubicinDelayed-Action PreparationsGlutathione

Autor:innen und Institutionen

  • Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin, 300070, People's Republic of China.
  • National Demonstration Center for Experimental Preventive Medicine Education (Tianjin Medical University), Tianjin, 300070, People's Republic of China.

ORCID-Profile: Baiqi Wang

Zitieren

APA

Yuan, M., Wu, Y., Zheng, J., Wang, C., Wang, J., Zheng, Y., Wang, Y., & Wang, B. (2026). Microenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells. International Journal of Nanomedicine, Volume 21, 1-21. https://doi.org/10.2147/ijn.s604452

Vancouver

Yuan M, Wu Y, Zheng J, Wang C, Wang J, Zheng Y, et al. Microenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells. International Journal of Nanomedicine. 2026;Volume 21:1-21. doi:10.2147/ijn.s604452

BibTeX
@article{Yuan2026,
  author = {Yuan, Miao and Wu, Yang and Zheng, Jing and Wang, Chaoran and Wang, Jiarong and Zheng, Yifan and Wang, Yunqi and Wang, Baiqi},
  title = {Microenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--21},
  doi = {10.2147/ijn.s604452}
}
Kostenlos starten →